Log in to save to my catalogue

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associate...

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associate...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9594bf99360a4fe291a094b11e902095

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

About this item

Full title

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Publisher

London: BioMed Central Ltd

Journal title

Alzheimer's research & therapy, 2020-09, Vol.12 (1), p.1-118, Article 118

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Blood-based biomarkers for Alzheimer's disease (AD) might facilitate identification of participants for clinical trials targeting amyloid beta (Abeta) accumulation, and aid in AD diagnostics. We examined the potential of plasma markers Abeta.sub.(1-42/1-40), glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) to identify...

Alternative Titles

Full title

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9594bf99360a4fe291a094b11e902095

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9594bf99360a4fe291a094b11e902095

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-020-00682-7

How to access this item